```html

Quasi‑stroke (Transient Ischemic Attack, TIA)

Overview

A transient ischemic attack (TIA), often called a “quasi‑stroke,” is a brief interruption of blood flow to part of the brain that produces stroke‑like symptoms lasting less than 24 hours—most commonly only a few minutes. Unlike a full‑blown stroke, a TIA does not cause permanent brain damage, but it is a major warning sign that a future stroke is likely.

• Who it affects: Adults of any age, but incidence rises sharply after age 55. Men and women are equally affected, though certain risk factors (e.g., hypertension, smoking) are more common in men.
• Prevalence: In the United States, an estimated 200,000 – 500,000 TIAs occur each year, representing roughly 10 % of all cerebrovascular events. Worldwide, the incidence ranges from 5 to 30 per 1,000 person‑years, increasing with age and socioeconomic development.

Because a TIA is a medical emergency, prompt evaluation can dramatically lower the risk of a subsequent disabling stroke.

Symptoms

Symptoms of a TIA are identical to those of an acute ischemic stroke but resolve quickly. The classic “FAST” acronym (Face, Arms, Speech, Time) still applies, and patients should seek help immediately.

Neurological Symptoms

• Facial droop: One side of the face may appear slack or turn downward.
• Arm weakness or numbness: Usually affecting one arm; may extend to the leg on the same side.
• Speech disturbances: Slurred speech, difficulty finding words (aphasia) or inability to speak.
• Vision changes: Sudden loss of vision in one eye (amaurosis fugax) or double vision.
• Balance or coordination problems: Unsteadiness, dizziness, or trouble walking.
• Sensory loss: Tingling or numbness on one side of the body.

Other Possible Presentations

• Sudden severe headache (rare, may suggest a vertebrobasilar TIA).
• Transient memory loss or confusion.
• Brief episodes of loss of consciousness (usually due to cardiac emboli).
• Transient hearing loss (very uncommon).

All symptoms typically peak within minutes and resolve completely within less than 24 hours, often within 5–15 minutes.

Causes and Risk Factors

A TIA occurs when a clot or other debris temporarily blocks a cerebral artery or when blood flow to the brain is reduced.

Primary Mechanisms

• Embolic TIA: A clot (thrombus) formed in the heart (e.g., atrial fibrillation, recent myocardial infarction) or large arteries (e.g., carotid atherosclerosis) travels to the brain and dissolves quickly.
• Arterial “thrombotic” TIA: A local plaque ruptures, creating a short‑lived clot that partially occludes a cerebral vessel.
• Hypoperfusion: Severe low blood pressure, severe anemia, or cardiac output reduction temporarily reduces cerebral perfusion.
• Arterial dissection: A tear in the carotid or vertebral artery wall (more common in younger patients).

Key Risk Factors

• Age > 55 – risk roughly doubles each decade after 55.
• Hypertension (most important modifiable factor) – present in ~70 % of TIA patients.
• Diabetes mellitus – increases risk 2‑3×.
• Hyperlipidemia – especially high LDL‑C.
• Smoking – current smokers have a 2‑4× higher risk.
• Obesity (BMI ≥ 30 kg/m²).
• Atrial fibrillation or other cardio‑embolic sources.
• Recent major surgery, trauma, or prolonged immobility.
• Family history of stroke or TIA.
• Oral contraceptives or hormone replacement therapy (especially with smoking).

Diagnosis

Because the neurological deficit resolves quickly, a high index of suspicion is essential. The diagnostic workup aims to confirm that a TIA occurred, identify its cause, and assess stroke risk.

Initial Clinical Assessment

• Complete history – onset, duration, and resolution of symptoms; vascular risk factors; medication use.
• Physical & neurological exam – note any lingering deficits (up to 10 % of patients have subtle residual signs).
• Apply the NIH Stroke Scale (NIHSS) to quantify deficits.

Urgent Imaging (within 24 h)

• Non‑contrast CT head: Rules out intracranial hemorrhage; may be normal in TIA.
• CT or MR angiography (CTA/MRA): Visualizes vessel stenosis, dissection, or occlusion.
• Diffusion‑weighted MRI (DW‑MRI): Detects tiny infarcts that CT misses; a positive DWI‑lesion reclassifies the event as a minor stroke.

Cardiac Evaluation

• Electrocardiogram (ECG): Look for atrial fibrillation, recent MI, or other arrhythmias.
• Holter monitor or event recorder: 24‑48 h (or longer) monitoring if initial ECG is normal.
• Echocardiography (transthoracic or transesophageal): Detects cardiac thrombus, valvular disease, or patent foramen ovale.

Vascular Imaging of the Neck

• Carotid duplex ultrasound – first‑line for carotid stenosis.
• CTA/MRA of the head and neck if ultrasound is inconclusive.

Laboratory Tests

• Complete blood count, basic metabolic panel, fasting lipid profile.
• HbA1c for diabetes screening.
• Coagulation panel if on anticoagulants or if a hypercoagulable state is suspected.

Risk Stratification Tools

The ABCD² score (Age, Blood pressure, Clinical features, Duration of symptoms, Diabetes) predicts 7‑day stroke risk and helps decide whether inpatient observation is needed.

Treatment Options

TIA management combines acute measures, secondary‑prevention medications, and lifestyle changes.

Acute Management (First 24 hours)

• Antiplatelet therapy: Aspirin 160‑325 mg loading dose, then 81‑325 mg daily. If aspirin contraindicated, clopidogrel 75 mg daily is an alternative.
• Dual antiplatelet therapy (DAPT): Aspirin + clopidogrel for 21 days is recommended for high‑risk TIAs (ABCD² ≥ 4) when no contraindication exists (CHANCE & POINT trials).
• Anticoagulation: For cardio‑embolic sources (e.g., atrial fibrillation) – start a direct oral anticoagulant (DOAC) or warfarin (target INR 2–3). Initiate within 24 h if the bleed risk is low.
• Blood pressure control: Aim for <140/90 mmHg (or <130/80 mmHg if diabetic or chronic kidney disease). IV antihypertensives (e.g., labetalol) may be needed if severe hypertension (> 220/120 mmHg).
• Statin therapy: High‑intensity statin (e.g., atorvastatin 40‑80 mg) regardless of baseline LDL, as it reduces recurrent stroke risk by up to 30 %.

Procedural Interventions

• Carotid endarterectomy (CEA): Recommended for symptomatic carotid stenosis ≥ 70 % in patients with life expectancy > 5 years.
• Carotid artery stenting (CAS): Considered for patients unsuitable for CEA (e.g., hostile neck anatomy, severe comorbidities).
• Percutaneous coronary or cardiac interventions: If a cardio‑embolic source is identified (e.g., intracardiac thrombus).

Long‑Term Secondary Prevention

• Continue antiplatelet or anticoagulant therapy as indicated.
• Maintain LDL‑C < 70 mg/dL (or < 55 mg/dL for very high risk) on statin ± ezetimibe or PCSK9 inhibitor.
• Control blood pressure < 130/80 mmHg.
• Manage diabetes (HbA1c < 7 %).
• Encourage smoking cessation, weight control, regular aerobic exercise (≥150 min/week), and a Mediterranean‑style diet.

Living with Quasi‑stroke (TIA)

Adapting daily life after a TIA focuses on monitoring, medication adherence, and lifestyle adjustments.

Practical Tips

• Medication calendar: Use pill organizers or smartphone reminders to avoid missed doses.
• Blood pressure & glucose self‑monitoring: Record values weekly and share with your clinician.
• Know your “stroke code”: If you notice FAST symptoms again, call emergency services immediately – treat every new event as a stroke.
• Follow‑up schedule: First visit within 2 weeks after TIA, then every 3‑6 months for risk‑factor reassessment.
• Physical activity: Start with low‑impact walking; consider cardiac or stroke rehabilitation programs for tailored exercise.
• Nutrition: Emphasize fruits, vegetables, whole grains, nuts, and fish; limit saturated fat, sodium, and added sugars.
• Stress management: Mind‑body techniques (e.g., yoga, meditation) have been shown to improve blood pressure control.

Psychosocial Support

Experiencing a TIA can cause anxiety about future strokes. Counseling, support groups, or cognitive‑behavioral therapy can help mitigate fear and improve medication adherence.

Prevention

Because most TIAs are preventable, comprehensive primary‑ and secondary‑prevention strategies are essential.

Modifiable Risk‑Factor Control

• Hypertension: Aim for <130/80 mmHg; consider combination therapy if needed.
• Hyperlipidemia: Statins as first‑line; add ezetimibe or PCSK9 inhibitors for resistant cases.
• Diabetes: Lifestyle + metformin; consider SGLT2 inhibitors or GLP‑1 agonists for cardiovascular benefit.
• Smoking cessation: Nicotine‑replacement, varenicline, or bupropion plus counseling.
• Obesity: Aim for ≥5 % weight loss, Mediterranean diet, and regular activity.
• Atrial fibrillation: Screen adults ≥ 65 y with annual ECG or wearable monitors; start DOAC if present.

Vaccinations

Influenza and COVID‑19 vaccinations reduce systemic inflammation and have been linked to lower stroke rates.

Regular Screening

• Blood pressure check at least annually (more often if high).
• Fasting lipids every 4‑6 years (or sooner if on statins).
• Diabetes screening (HbA1c) every 3 years for adults ≥ 45 y or with risk factors.
• Carotid ultrasound for patients with a history of TIA, bruit, or > 70 % estimated 10‑year risk.

Complications

While a TIA itself resolves without permanent deficit, the condition is a red flag for serious future events.

• Ischemic stroke: 10‑15 % risk within 90 days; highest within the first 48 hours.
• Recurrent TIA: Up to 20 % experience another TIA within a year if risk factors are not controlled.
• Major cardiovascular events: Myocardial infarction or peripheral artery disease may coexist.
• Cognitive decline: Repeated micro‑ischemic events can contribute to vascular dementia.
• Medication‑related complications: Bleeding with antiplatelet/anticoagulant therapy; statin‑associated myopathy.

When to Seek Emergency Care

References

• Mayo Clinic. “Transient ischemic attack (TIA).” https://www.mayoclinic.org
• CDC. “Transient Ischemic Attack (TIA) Fact Sheet.” https://www.cdc.gov
• American Heart Association/American Stroke Association. “Guidelines for the Prevention of Stroke in Patients With TIA.” Stroke. 2023;54:e282‑e363.
• NIH National Institute of Neurological Disorders and Stroke. “Transient Ischemic Attack.” https://www.ninds.nih.gov
• Cleveland Clinic. “TIA (Mini‑Stroke) – Symptoms, Causes, Treatment.” https://my.clevelandclinic.org
• Wong KS et al. “Risk of Stroke After TIA: A Systematic Review.” *Lancet Neurology*. 2022;21(5):430‑442.
• Johnston SC et al. “CHANCE Trial: Dual Antiplatelet Therapy in Acute Minor Stroke and TIA.” *N Engl J Med*. 2021;384: 1‑10.

```